Appili Therapeutics Overview

  • Founded
  • 2015

Founded
  • Status
  • Public

  • Employees
  • 12

Employees
  • Stock Symbol
  • APLI

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $0.04

  • (As of Friday Closing)

Appili Therapeutics General Information

Description

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TSE
Primary Office
  • 1344 Summer Street
  • Suite 21
  • Halifax, Nova Scotia B3H 0A8
  • Canada
+1 (902) 000-0000

Appili Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Appili Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.04 $0.04 - $0.85 $4.89M 121M 105K -$0.23

Appili Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 5,708 1,854 39,933 21,156
Revenue 1,098 1,109 0 150
EBITDA (14,493) (18,773) (10,849) (4,079)
Net Income (15,851) (20,027) (10,824) (4,071)
Total Assets 5,538 6,634 14,511 7,879
Total Debt 4,062 3,988 818 709
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Appili Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Appili Therapeutics‘s full profile, request access.

Request a free trial

Appili Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective th
Drug Discovery
Halifax, Canada
12 As of 2022
000.00
00000000 000.00

000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000000000000
San Diego, CA
00 As of 0000
00000
000000 - 000 00000

000000

uis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Appili Therapeutics Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cidara Therapeutics Formerly VC-backed San Diego, CA 00 00000 000000 - 000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
00000 00000 000000 Private Equity-Backed Geneva, Switzerland 00 00000 00000000000 00000
000000 Venture Capital-Backed Lebanon, NH 000 00000 0000000000 0 00000
00000000 Formerly VC-backed Alameda, CA 000 00000 000000000 00000
You’re viewing 5 of 35 competitors. Get the full list »

Appili Therapeutics Patents

Appili Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3155443-A1 Composition and method for treating candida auris infection Pending 04-Nov-2019 0000000000
US-20220257578-A1 Composition and method for treating candida auris infection Pending 04-Nov-2019 0000000000
EP-3768321-A4 Oral formulations of metronidazole and methods of treating an infection using same Pending 16-Jan-2018 0000000000 0
US-20210069153-A1 Oral formulations of metronidazole and methods of treating an infection using same Pending 16-Jan-2018 0000000000
CA-3087789-A1 Oral formulations of metronidazole and methods of treating an infection using same Pending 16-Jan-2018 A61K31/4164
To view Appili Therapeutics’s complete patent history, request access »

Appili Therapeutics Executive Team (11)

Name Title Board Seat Contact Info
Armand Balboni Ph.D Chief Executive Officer & Board Member
Kevin Sullivan Founder, Chief Executive Officer & Board Member
Kenneth Howling Acting Chief Financial Officer
Don Cilla Executive
Yoav Golan MD Chief Medical Officer
You’re viewing 5 of 11 executive team members. Get the full list »

Appili Therapeutics Board Members (16)

Name Representing Role Since
Armand Balboni Ph.D Appili Therapeutics Chief Executive Officer & Board Member 000 0000
Brian Bloom Bloom Burton & Co. Board Member 000 0000
Ian Mortimer Self Chairman & Board Member 000 0000
John Holyoake Ph.D Bloom Burton & Co. Board Member 000 0000
Josef Vejvoda Self Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Appili Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Appili Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Appili Therapeutics‘s full profile, request access.

Request a free trial

Appili Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 21-Nov-2019 000000000 Buildings and Property 00000 000
To view Appili Therapeutics’s complete investments history, request access »